Welcome to the Stocktwits Top 25 Newsletter for Week 38 of 2023!
The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time.
Here are the Stocktwits Top 25 Lists for Week 38:
P.S. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!
Standard and Poor's 500
ST Top 25 S&P 500
The S&P 500 Top 25 list (-3.65%) underperformed the S&P 500 index (-2.93%).
There were two major changes to the list this week.
Joining: FedEx Corp (+2.76%) and Lam Research Corp (-0.64%).
Leaving: Align Technology (-10.10%) and ServiceNow (-4.40%).
Check out how the momentum meter has performed vs. the S&P 500 index this year:
The Large-Cap Nasdaq 100
The Nasdaq 100 Top 25 list (-4.05%) underperformed the Nasdaq 100 index (-3.30%).
There was one major change to the list this week.
Synopsys Inc (-1.12%) replaced Workday (-4.17%) on the list.
The Growth-Centric Russell 2000
The Russell 2000 Top 25 list (-5.48%) underperformed the Russell 2000 index (-3.82%).
There were three major changes to the list this week.
Joining: Mimedx Group (+0.53%), Cimpress PLC (+4.45%), and Innodata (-2.65%).
Leaving: Cardlytics (-24.80%), Eyepoint Pharmaceuticals (-19.37%), and Marathon Digital (-11.53%).
ST Top 25 TOP DAWG OF THE WEEK 🐶
The Top 25 lists’ Top Dawg was Inozyne Pharma, which rallied 6.98%. 📈
There was not any specific news about the small-cap clinical-stage biopharmaceutical company driving this move. It looks to be benefitting from continued investor interest in micro and small-cap biotech companies. 🤷
The company will host a virtual investor and analyst event on September 26, 2023, which could move the stock. 📝
$INZY is up 338.10% YTD.
See Y’all Next Week 🤙